C31G
- Generic Name
- C31G
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C30H64N2O3
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Background
C31G is a potent broad spectrum antimicrobial agent, effective against gram positive and gram negative bacteria, yeast and fungi.C31G, vaginal gel is developed by Biosyn Inc. and has commenced enrollment in a phase III pivotal clinical trial for the reduction of sexual transmission of human immunodeficiency virus (HIV).
- Indication
Investigated for use/treatment in contraception, HIV infection, and prevention of stdis.
- Associated Conditions
- -
- Associated Therapies
- -
Effectiveness of Three Different Mouthrinses in Dental Plaque Control and Early Wound Healing
- Conditions
- Interventions
- First Posted Date
- 2017-04-19
- Last Posted Date
- 2017-08-24
- Lead Sponsor
- National and Kapodistrian University of Athens
- Target Recruit Count
- 42
- Registration Number
- NCT03119831
Study of the Safety and Contraceptive Efficacy of C31G Compared to Conceptrol®
- First Posted Date
- 2006-01-10
- Last Posted Date
- 2018-05-01
- Lead Sponsor
- Health Decisions
- Target Recruit Count
- 1565
- Registration Number
- NCT00274261
- Locations
- 🇺🇸
U.T. Southwestern Medical Center, Dallas, Texas, United States
🇺🇸California Family Health Council, Los Angeles, California, United States
🇺🇸University of Colorado - Advanced reproductive Medicine, Aurora, Colorado, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.